Bimekizumab for treating moderate to severe plaque psoriasis

Register of interests (PDF 146 KB)

Equality Impact Assessment (Guidance development) (PDF 146 KB)

Final draft guidance: 1

Final appraisal document (PDF 208 KB)

Committee papers (PDF 1.67 MB)

Final scope (PDF 218 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 416 KB)

Equality impact assessment (Scoping) (PDF 125 KB)

Final stakeholder list (PDF 187 KB)

Draft scope post referral (PDF 231 KB)

Draft matrix post referral (PDF 186 KB)